ZyVersa Therapeutics, (ZVSA) Institutional Ownership

Track institutional investors, ownership changes, and 13F filings.

Ownership Summary
Total Institutions
Total Shares Held -
Total Value $-
Institutional Holding % %
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of )
Institution Shares Ownership % Value
Recent Insider Trading
Insider Title Transaction Shares Value Date
Cashmere Karen A. Director A-Award 572 $87.21K May 24, 2023
Wolfe Peter Chief Financial Officer A-Award 715 $109.01K May 24, 2023
Glover Stephen C. Director, Chief Executive Officer A-Award 1.63K $248.05K May 24, 2023
Park Min-Chul Director A-Award 132 $20.12K May 24, 2023
Freitag Gregory Gene Director A-Award 132 $20.12K May 24, 2023
Sapirstein James Director A-Award 132 $20.12K May 24, 2023
Finizio Robert G Director A-Award 132 $20.12K May 24, 2023
Incon Co., Ltd. 10 Percent Owner: - $- May 10, 2023
Guzman Pablo A. Chief Medical Officer A-Award 100.00K $- Jan 26, 2023
Guzman Pablo A. Chief Medical Officer 9.02K $62.20K Dec 12, 2022
Recent Position Changes
Institution Shares Changed % Change Date
Recent Ownership Filings

Related Metrics

Explore detailed financial metrics and analysis for ZVSA.